Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by Mt69sinaion Feb 28, 2019 11:41am
282 Views
Post# 29423266

CANNABIS COMPANIES PURSUING GROWTH SET SIGHTS ON LATINA AMER

CANNABIS COMPANIES PURSUING GROWTH SET SIGHTS ON LATINA AMER

CANNABIS COMPANIES PURSUING GROWTH SET SIGHTS ON LATINA AMERICA

LESS THAN 1 MINUTE AGO BY

Aphria Inc. (NYSE: APHA) (TSX: APHA) is a leading global cannabis company driven by an unrelenting commitment to our people, product quality and innovation. Aphria Inc. recently announced that its Colombian subsidiary, Colcanna SAS has signed an exclusive agreement with the Federacin Mdica Colombiana, a national guild that oversees the ethical exercise of the medical profession in Colombia, to jointly develop an academic curriculum on the medicinal use of cannabis. The FMC has nearly 2,000 affiliated doctors and a database of more than 70,000 medical professionals that access the organization for research and educational resources, including through a virtual platform that offers certified courses on a range of subjects. The medical cannabis curriculum developed by Colcanna and FMC will be made accessible on this platform and will be supported by scientific events for the medical community. "Education in the medical community is critical for sustaining the advancement of medical cannabis in Colombia" said Gabriel Meneses, Vice President, LATAM & Caribbean at Aphria. "Colcanna is proud to make this exclusive arrangement with Federacin Mdica Colombiana, which will offer doctors and medical professionals across the country a credible and trusted source of information and training on medical cannabis."

glta and congrats Longs!! Lots to come next 6 trading days IMO 

$$$$$APHA$$$$$

$inai

 
Bullboard Posts